ggggggggg

Method for predicting the response to tnf inhibitors

Rheumatoid arthritis (RA) is the most prevalent chronic autoimmune inflammatory rheumatism. Its pathophysiology is largely dependent on TNF. Severe RA […]

Methods for prognosis and monitoring of critical form of coronavirus

In the present invention, inventors investigate the representation of neutrophil subsets in severe and critical COVID-19 patients based on Intensive […]

Use of slamf1 as a biomarker in colorectal cancer

Innate lymphoid cells (ILCs) are tissue-resident lymphocytes that differ from conventional T lymphocytes in having no antigen-specific receptors. ILCs […]

Use of cd160 as a biomarker in acute myeloid leukemia

Natural killer (NK) cells are innate cytotoxic lymphoid cells (ILCs) involved in the killing of infected and tumor cells. Several NK cell subsets have […]

Method for treating and prognosing cancer like glioblastoma

The present invention relates the treatment and prognostic of cancer like glioblastoma. Here, the inventors focused their study on the impact of […]

Bile salts bactosensor and use thereof for diagnostic and therapeutic

Bile salts are steroid acids derived from cholesterol in the liver, are released into the gastrointestinal tract to aid in digestion and are […]

Methods and compositions to determine the quality of red blood cell

The present invention relates to a method for determining the quality of haemoglobin (Hb) during the storage period of red blood cell (RBC) units […]

Methods for discontinuing a treatment with a tyrosinekinase inhibitor

The present invention relates to a method for discontinuing a treatment with a TKI by determining the number and/or frequency of innate CD8(+) T-cells […]

Methods for diagnosing nasal intestinal type adenocarcinomas

The present invention relates to methods and compositions for the diagnostic and for the treatment of nasal intestinal type adenocarcinomas (ITAC). […]

New biomarkers for predicting antipsychotic treatment response in a

A fundamental shortcoming in the current treatment of schizophrenia is the lack of valid criteria to predict who will respond to antipsychotic […]